These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11600461)

  • 1. Antagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
    Freston JW
    Gut; 2001 Nov; 49(5):616-7. PubMed ID: 11600461
    [No Abstract]   [Full Text] [Related]  

  • 2. Protagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
    Labenz J
    Gut; 2001 Nov; 49(5):614-6. PubMed ID: 11600460
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease].
    Vasil'ev IuV; Nikol'skaia KA
    Eksp Klin Gastroenterol; 2005; (6):61-4. PubMed ID: 17378390
    [No Abstract]   [Full Text] [Related]  

  • 4. Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat?
    O'Connor HJ; O'Morain CA
    Scand J Gastroenterol; 2001 Jul; 36(7):677-82. PubMed ID: 11444465
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori infection and long term proton pump inhibitor therapy.
    McColl KE
    Gut; 2004 Jan; 53(1):5-7. PubMed ID: 14684566
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evidence based conservative therapy of gastroesophageal reflux].
    Schilling D; Riemann JF
    Internist (Berl); 2003 Jan; 44(1):21-7. PubMed ID: 12677701
    [No Abstract]   [Full Text] [Related]  

  • 7. [Eradication of Helicobacter pylori possibly followed by gastroesophageal reflux disease].
    Loffeld RJ
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2505-7. PubMed ID: 10627750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Helicobacter eradication in gastritis and ulcers. Causal therapy, prevention of stomach cancer].
    MMW Fortschr Med; 2003 Aug; 145(33-34):54-5. PubMed ID: 14526576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Helicobacter pylori: changes of indications for eradication therapy].
    Koop H
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S91-3. PubMed ID: 15368180
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.
    Jonaitis L; Kiudelis G; Kupcinskas L
    Medicina (Kaunas); 2008; 44(3):211-5. PubMed ID: 18413988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroesophageal reflux in the adult: what are the results of medical treatments? (II)].
    Zerbib F
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S255-73. PubMed ID: 10078456
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of gastroesophageal reflux: should Helicobacter pylori infection be taken into account?].
    De Korwin JD
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S121-9. PubMed ID: 10078440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Eradication euphoria is passé. Does H. pylori protect against reflux?. Interview by Dr. Brigitte Moreano].
    Riemann J
    MMW Fortschr Med; 2000 Sep; 142(38):8. PubMed ID: 11050882
    [No Abstract]   [Full Text] [Related]  

  • 14. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing one PPI treatment over another.
    Dachs R; Darby-Stewart A; Graber M
    Am Fam Physician; 2007 Nov; 76(9):1273-4. PubMed ID: 18019869
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastro-oesophageal reflux and Helicobacter pylori.
    Pace F; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the only good H. pylori a dead H. pylori?
    Fennerty MB
    Gastroenterology; 1996 Dec; 111(6):1773-4. PubMed ID: 8942763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.